Enlivex Therapeutics Ltd. Ordinary Shares

$0.9197
+0.0827 (+9.88%)

Volume:

1.574K ($1.45K)

Market Capitalization:

$221.69M

Enlivex Therapeutics Price Chart

Enlivex Therapeutics Price Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM0.91970.90510.89060.87600.86140.84690.83

Enlivex Therapeutics Volume Chart

Enlivex Therapeutics Volume Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM10.60K9.09K7.57K6.06K4.54K3.03K1.51K

Enlivex Therapeutics Market Segments

Premarket

+0.0550(+6.36%)
Open$0.8647
Close$0.9197
Low$0.8640
Low Change-0.0007 (-0.08%)
High$0.9198
High Change+0.0551 (+6.37%)
Range$0.0558
Volume1.574K
Dollar Volume$1.45K

After Hours Yesterday

+0.0000(+0.00%)
Open$0.8480
Close$0.8480
Low$0.8480
Low Change0.0000 (0.00%)
High$0.8480
High Change+0.0000 (+0.00%)
Range$0.0000
Volume250
Dollar Volume$212.00

Regular Trading Hours Yesterday

-0.0330(-3.79%)
Open$0.8700
Close$0.8370
Low$0.8266
Low Change-0.0434 (-4.99%)
High$0.9000
High Change+0.0300 (+3.45%)
Range$0.0734
Volume304.9K
Dollar Volume$255.20K

Premarket Yesterday

+0.0200(+2.27%)
Open$0.8800
Close$0.9000
Low$0.8800
Low Change0.0000 (0.00%)
High$0.9000
High Change+0.0200 (+2.27%)
Range$0.0200
Volume660
Dollar Volume$594.00

Enlivex Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.8871
10 Day Moving Average (SMA10)$0.8733
20 Day Moving Average (SMA20)$0.8898
50 Day Moving Average (SMA50)$1.0197
100 Day Moving Average (SMA100)$0.9966
200 Day Moving Average (SMA200)$1.0634

Enlivex Therapeutics Statistics

Average Volume (30 Days)879.1K
P/E Ratio (Current)-17.60
EPS (Current)-$0.05
Dividend Yield0.00%
Free Cash Flow-$7.19M
Cash Ratio1.30
Current Ratio1.85
Quick Ratio1.85
Debt to Equity0.00
Enterprise Value$206.45M
EV to EBITDA-20.29
EV to Sales
Price to Book5.98
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.29%
Return on Equity-0.33%

Enlivex Therapeutics Stock Splits

There have been 2 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on March 6, 2019 and reduced the outstanding shares at a ratio of 8:1.

DateTypeRatio
Mar 6, 2019Reverse8:1
Sep 25, 2017Reverse5:1

Enlivex Therapeutics Dividends

There have been no dividends for Enlivex Therapeutics (ENLV).